1. National Comprehensive Cancer Network. Non-small cell lung cancer NCCN guidelines version 3.2019. Available at: www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed April 16, 2019.
2. Treatment of Stage I and II Non-small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Howington;Chest,2013
3. Lim E, Dunning J, Shackcloth M, Anikin V, Naidu B, Belcher E, et al. In: Hospital Clinical Efficacy, Safety and Oncologic Outcomes from VIOLET: A UK Multi-Centre RCT of VATS Versus Open Lobectomy for Lung Cancer [abstract]. In: Plenary Session - Presidential Symposium of the IASLC 2019 World Conference on Lung Cancer; September 7-10, 2019; Barcelona, Spain. Abstract ID 1257.
4. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases;Stephens;Eur J Cardiothorac Surg,2014
5. A national analysis of long-term survival following thoracoscopic versus open lobectomy for stage I non-small-cell lung cancer;Yang;Ann Surg,2019